Hard To Treat Stock Probability Of Bankruptcy
Hard To's chance of distress is under 32% at this time. It has slight odds of undergoing some form of financial distress in the near future. Hard To's Probability of financial unrest is determined by interpolating and adjusting Hard Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Hard balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Hard To Piotroski F Score and Hard To Altman Z Score analysis.
Hard | Probability Of Bankruptcy |
Hard to Treat Company probability of financial unrest Analysis
Hard To's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Hard To Probability Of Bankruptcy | Less than 32% |
Most of Hard To's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hard to Treat is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Hard To probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Hard To odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Hard to Treat financial health.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hard To. If investors know Hard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hard To listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Quarterly Revenue Growth 0.057 |
The market value of Hard to Treat is measured differently than its book value, which is the value of Hard that is recorded on the company's balance sheet. Investors also form their own opinion of Hard To's value that differs from its market value or its book value, called intrinsic value, which is Hard To's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hard To's market value can be influenced by many factors that don't directly affect Hard To's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hard To's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hard To is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hard To's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Hard to Treat has a Probability Of Bankruptcy of 32.0%. This is 26.08% lower than that of the Biotechnology sector and 41.65% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 19.66% higher than that of the company.
Hard Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hard To's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hard To could also be used in its relative valuation, which is a method of valuing Hard To by comparing valuation metrics of similar companies.Hard To is currently under evaluation in probability of bankruptcy category among its peers.
Hard Fundamentals
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 254.37 K | ||||
| Shares Outstanding | 5.48 B | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 5.39 M | ||||
| Gross Profit | 1.42 M | ||||
| EBITDA | 1.03 M | ||||
| Net Income | 621.6 K | ||||
| Cash And Equivalents | 202.9 K | ||||
| Total Debt | 1.54 M | ||||
| Debt To Equity | 0.21 % | ||||
| Current Ratio | 2.27 X | ||||
| Cash Flow From Operations | 655.71 K | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 54.82 K | ||||
| Total Asset | 4.56 M | ||||
| Retained Earnings | 1.4 M | ||||
| Working Capital | (508 K) | ||||
| Current Asset | 596 K | ||||
| Current Liabilities | 1.1 M | ||||
| Net Asset | 4.56 M |
About Hard To Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hard to Treat's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hard To using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hard to Treat based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hard Stock Analysis
When running Hard To's price analysis, check to measure Hard To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hard To is operating at the current time. Most of Hard To's value examination focuses on studying past and present price action to predict the probability of Hard To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hard To's price. Additionally, you may evaluate how the addition of Hard To to your portfolios can decrease your overall portfolio volatility.